Development of Treatments for Intellectual and Developmental Disabilities
NIH Campus, Bethesda, MD
The purpose of this meeting is to bring together representatives from the research community, the Government (NIH, FDA), pharmaceutical companies and constituency groups to discuss the special challenges of developing treatments for a population with intellectual and developmental disabilities.
Tiina K. Urv, Ph.D., NICHD (301) 402-7015 firstname.lastname@example.org
National Institute of Child Health and Human Development
Office of Rare Diseases Research
From the National Center for Advancing Translational Sciences
From the National Institutes of Health